Greg Chrimes

Greg Chrimes has extensive work experience in the biopharmaceutical industry. Greg began their career at Amgen in 1999, where they worked as a Scientist and later became the Manager of Analytical Sciences. At Amgen, they were responsible for protein characterization and played a key role in supporting the structure component of therapeutic Biologic License Applications.

In 2014, Greg joined KBI Biopharma as the Director of Analytical and Process Development. Greg successfully managed resources and provided leadership in various client projects, including analytical method lifecycle management, product and process characterization, Quality Control support, Manufacturing support, and Regulatory strategy. Greg then moved up to the position of Senior Director and later Vice President, overseeing the Analytical and Formulation Sciences department.

Throughout their career, Greg has demonstrated expertise in analytical sciences and process development, contributing to the advancement of biopharmaceutical research and development.

Greg Chrimes studied Biochemistry and Cell Biology at the University of Northern Colorado. No information is provided regarding the start and end years or the degree obtained.